• Product NameIniparib (BSI-201)
• Brief DescriptionInhibitors
• Purification99.00%
• Biological ActivityIniparib (BSI-201) is a PARP1 inhibitor with demonstrated effectiveness in triple-negative breast Y (TNBC). Phase 3.
• Target NamePARP inhibitor
• CAS No. 160003-66-7
• Calculated MW 292.03
• Formulation C7H5IN2O3
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cancer
  SMILES:NC(=O)C1=CC(=C(I)C=C1)[N+]([O-])=O
  Pathways:Chromatin/Epigenetic; DNA Damage/DNA Repair
  Receptor:PARP1
  Boling pt:
  Melting pt:
  Solubility:Ethanol: 28 mg/mL (95.88 mM); DMSO: 58 mg/mL (198.6 mM)
  Appearance:YellowCrystal
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Mendeleyev J, et al. Biochem Pharmacol, 1995, 50(5), 705-714.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting